Exchange: NYSEMkt·Updated 07:56 PM EDT
APUS logo

APUS Apimeds Pharmaceuticals US Inc.

$1.77
$0.10
(5.99%)
Today
Closed $1.77
$0.16
(9.04%)
After Hours
Mkt Cap$2.67M
Vol1.34M

About APUS

Apimeds Pharmaceuticals US, Inc. is a clinical stage biopharmaceutical company that engages in the development of Apitox, an intradermally administered bee venom-based toxin. It primarily focuses on developing innovative therapies for inflammation and pain management in knee osteoarthritis (OA) and, to a lesser extent, multiple sclerosis (MS). The company was founded on May 11, 2020 and is headquartered in Matawan, NJ.
59

Bullish Sentiment

How do you feel about APUS?

Advertisement|Remove ads.